UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Burns J W & Co. Inc. NY

Burns J W & Co. Inc. NY trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,589 shares of the healthcare conglomerate’s stock after selling 126 shares during the quarter. UnitedHealth Group makes up 1.1% of Burns J W & Co. Inc. NY’s portfolio, making the stock its 27th biggest holding. Burns J W & Co. Inc. NY’s holdings in UnitedHealth Group were worth $8,530,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after acquiring an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in UnitedHealth Group by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp increased its stake in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after purchasing an additional 21,149 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on UNH. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price target for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Robert W. Baird boosted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company boosted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Down 0.3 %

Shares of NYSE:UNH traded down $1.55 during trading on Friday, hitting $591.20. The company’s stock had a trading volume of 2,463,201 shares, compared to its average volume of 3,965,528. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The stock’s 50-day moving average price is $582.24 and its two-hundred day moving average price is $527.36. The company has a market capitalization of $544.13 billion, a PE ratio of 36.14, a PEG ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the previous year, the firm posted $6.14 earnings per share. The company’s revenue was up 6.4% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.